Emergent Biosolutions EBS Income Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $742.9M-28.8% | $1.04B-0.5% | $1.05B-6.1% | $1.12B-37.0% | ||
| $326.2M-52.1% | $681.3M-3.4% | $705.4M+1.7% | $693.4M— | ||
| $416.7M+15.0% | $362.3M+5.4% | $343.9M-18.9% | $424.1M— | ||
| 56.1%+21.4pp | 34.7%+1.9pp | 32.8%-5.2pp | 38%— | ||
| $53.2M-24.8% | $70.7M-36.5% | $111.4M-39.9% | $185.4M-21.2% | ||
| $186.1M-39.6% | $308M-16.4% | $368.4M+8.0% | $341.1M-2.2% | ||
| $65.1M0.0% | $65.1M-0.8% | $65.6M+9.5% | $59.9M+2.4% | ||
| $642.8M-44.2% | $1.15B-35.1% | $1.78B+38.0% | $1.29B-10.2% | ||
| —— | -$108.7M+85.0% | -$726.4M-327% | -$170M-150% | ||
| $59.3M-16.5% | $71M-19.2% | $87.9M+136% | $37.3M+8.1% | ||
| -$17.3M+49.4% | -$34.2M-613% | -$4.8M+90.2% | -$49M-28.3% | ||
| $0-100% | $24.3M— | —— | $0— | ||
| —— | -$142.9M+80.5% | -$731.2M-240% | -$215.2M-171% | ||
| $30.2M-36.7% | $47.7M— | —— | -$7.4M-109% | ||
| —— | -$190.6M+74.9% | -$760.5M-259% | -$211.6M-196% | ||
| —— | -$3.72+74.9% | -$14.83-250% | -$4.24-204% | ||
| —— | -$3.62+75.6% | -$14.83-250% | -$4.24-203% | ||
| 224.7M+5.3% | 213.4M+4.7% | 203.9M+1.6% | 200.7M-7.2% | ||
| 215.3M+2.1% | 210.9M+3.4% | 203.9M+1.6% | 200.7M-6.3% | ||
| $65.1M0.0% | $65.1M-0.8% | $65.6M+9.5% | $59.9M+2.4% | ||
| —— | —— | —— | —— | ||
| —— | —— | $6.4M— | —— | ||
| $742.9M-28.8% | $1.04B-0.5% | $1.05B— | —— | ||
| —— | -$108.7M+85.0% | -$726.4M-327% | -$170M-150% | ||
| —— | $100K+100% | -$601.3M-2,152% | -$26.7M-106% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Emergent Biosolutions's revenue?
- Emergent Biosolutions (EBS) generated $676.8M in revenue over the trailing twelve months, down 29.9% year over year.
- Is Emergent Biosolutions profitable?
- Emergent Biosolutions reported $114.0M in net income over the trailing twelve months, a 9.6% net margin.
- What are Emergent Biosolutions's profit margins?
- Gross margin is 54.2% and operating margin is 15.0%, with a 9.6% net margin.
- What is Emergent Biosolutions's earnings per share?
- Emergent Biosolutions's diluted EPS over the trailing twelve months is $1.95.
- Where does Emergent Biosolutions's income statement data come from?
- Every line is extracted from Emergent Biosolutions's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
